FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966006931> ?p ?o ?g. }

• W1966006931 endingPage "900" @default.
• W1966006931 startingPage "892" @default.
• W1966006931 abstract "Multiple forms of muscular dystrophy are due to the absence of cytoskeletal muscle proteins that normally protect the integrity of muscle cells. The lack of any adequate treatments for these devastating diseases propels research toward the development of strategies for gene delivery to skeletal muscle. High-capacity adenoviral vectors (HC-AdV) devoid of all viral coding sequences have been developed to avoid expression of viral proteins by the gene therapy vector. However, the capsid proteins that are an essential component of the input viral vector and any residual helper virus in the vector preparation could induce an immune response. Furthermore, the therapeutic protein provided by a gene transfer vector presents the potential to induce an immune response in a patient who does not express a normal cellular protein due to genetic mutation. Therefore, we hypothesize that some immune suppression will be required with therapeutic gene delivery designed for the treatment of patients with inherited muscle diseases. In this study, we constructed and rescued three HC-AdVs expressing murine CTLA4Ig, murine CD40Ig, or both. The backbone vector without a gene insert was rescued as a negative control vector. The production of relevant proteins from each vector was determined in vitro. In vivo function of each of the immunosuppressant vectors was assayed by co-injection with an enhanced green fluorescent protein (EGFP)-expressing first-generation adenoviral vector (AdEGFP) into the tibialis anterior muscle of C57BL/10 mice. Higher levels of muscle EGFP expression were observed in animals receiving an immunosuppressant vector. Furthermore, the production of total anti-AdV and anti-EGFP antibodies was reduced in mice treated with each of the three immunosuppressant vectors. A second intramuscular administration of AdEGFP alone 4 weeks after the initial co-injection was successful in all immunosuppressant vector-treated groups, but not in the negative control vector-treated group. All groups had a high antibody response to adenoviral proteins after the second injection of AdEGFP alone, indicating that the initial co-injection did not tolerize against vector capsid antigens." @default.
• W1966006931 created "2016-06-24" @default.
• W1966006931 creator A5024516045 @default.
• W1966006931 creator A5032018308 @default.
• W1966006931 creator A5044058894 @default.
• W1966006931 creator A5045902654 @default.
• W1966006931 creator A5052349035 @default.
• W1966006931 creator A5063055218 @default.
• W1966006931 creator A5088649964 @default.
• W1966006931 creator A5089060856 @default.
• W1966006931 date "2001-06-01" @default.
• W1966006931 modified "2023-10-09" @default.
• W1966006931 title "Local High-Capacity Adenovirus-Mediated mCTLA4Ig and mCD40Ig Expression Prolongs Recombinant Gene Expression in Skeletal Muscle" @default.
• W1966006931 cites W1513048819 @default.
• W1966006931 cites W1542616270 @default.
• W1966006931 cites W1565397798 @default.
• W1966006931 cites W1965172479 @default.
• W1966006931 cites W1965813064 @default.
• W1966006931 cites W1967228746 @default.
• W1966006931 cites W1967937424 @default.
• W1966006931 cites W1980283599 @default.
• W1966006931 cites W1980890790 @default.
• W1966006931 cites W1990328511 @default.
• W1966006931 cites W1990561446 @default.
• W1966006931 cites W2000853857 @default.
• W1966006931 cites W2011762615 @default.
• W1966006931 cites W2016006434 @default.
• W1966006931 cites W2021116207 @default.
• W1966006931 cites W2021319181 @default.
• W1966006931 cites W2034091304 @default.
• W1966006931 cites W2035600956 @default.
• W1966006931 cites W2036056711 @default.
• W1966006931 cites W2042834453 @default.
• W1966006931 cites W2064744205 @default.
• W1966006931 cites W2075921029 @default.
• W1966006931 cites W2087080914 @default.
• W1966006931 cites W2088494611 @default.
• W1966006931 cites W2090781939 @default.
• W1966006931 cites W2090864647 @default.
• W1966006931 cites W2108860107 @default.
• W1966006931 cites W2114445152 @default.
• W1966006931 cites W2131095976 @default.
• W1966006931 cites W2136776721 @default.
• W1966006931 cites W2140966875 @default.
• W1966006931 cites W2146261786 @default.
• W1966006931 cites W2148566884 @default.
• W1966006931 cites W2151902657 @default.
• W1966006931 cites W2155086276 @default.
• W1966006931 cites W2158244716 @default.
• W1966006931 cites W2160690575 @default.
• W1966006931 cites W2162466652 @default.
• W1966006931 cites W2163046219 @default.
• W1966006931 cites W2164903177 @default.
• W1966006931 cites W2164928522 @default.
• W1966006931 cites W2171021135 @default.
• W1966006931 cites W2313843498 @default.
• W1966006931 cites W2319705572 @default.
• W1966006931 cites W2327998567 @default.
• W1966006931 cites W4230774644 @default.
• W1966006931 doi "https://doi.org/10.1006/mthe.2001.0331" @default.
• W1966006931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11407903" @default.
• W1966006931 hasPublicationYear "2001" @default.
• W1966006931 type Work @default.
• W1966006931 sameAs 1966006931 @default.
• W1966006931 citedByCount "39" @default.
• W1966006931 countsByYear W19660069312012 @default.
• W1966006931 countsByYear W19660069312013 @default.
• W1966006931 countsByYear W19660069312015 @default.
• W1966006931 countsByYear W19660069312018 @default.
• W1966006931 crossrefType "journal-article" @default.
• W1966006931 hasAuthorship W1966006931A5024516045 @default.
• W1966006931 hasAuthorship W1966006931A5032018308 @default.
• W1966006931 hasAuthorship W1966006931A5044058894 @default.
• W1966006931 hasAuthorship W1966006931A5045902654 @default.
• W1966006931 hasAuthorship W1966006931A5052349035 @default.
• W1966006931 hasAuthorship W1966006931A5063055218 @default.
• W1966006931 hasAuthorship W1966006931A5088649964 @default.
• W1966006931 hasAuthorship W1966006931A5089060856 @default.
• W1966006931 hasBestOaLocation W19660069311 @default.
• W1966006931 hasConcept C104317684 @default.
• W1966006931 hasConcept C111599444 @default.
• W1966006931 hasConcept C135983454 @default.
• W1966006931 hasConcept C153911025 @default.
• W1966006931 hasConcept C203014093 @default.
• W1966006931 hasConcept C2779030066 @default.
• W1966006931 hasConcept C32470452 @default.
• W1966006931 hasConcept C40767141 @default.
• W1966006931 hasConcept C54355233 @default.
• W1966006931 hasConcept C86803240 @default.
• W1966006931 hasConcept C8891405 @default.
• W1966006931 hasConcept C92087593 @default.
• W1966006931 hasConcept C95444343 @default.
• W1966006931 hasConceptScore W1966006931C104317684 @default.
• W1966006931 hasConceptScore W1966006931C111599444 @default.
• W1966006931 hasConceptScore W1966006931C135983454 @default.
• W1966006931 hasConceptScore W1966006931C153911025 @default.
• W1966006931 hasConceptScore W1966006931C203014093 @default.
• W1966006931 hasConceptScore W1966006931C2779030066 @default.

• next